Get the Stockscreener App
0.9864
2.75%
0.0264
After Hours:
.99
0.0036
+0.36%
Gossamer Bio Inc stock is traded at $0.9864, with a volume of 544.75K.
It is up +2.75% in the last 24 hours and up +12.37% over the past month.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
See More
Previous Close:
$0.96
Open:
$0.976
24h Volume:
544.75K
Relative Volume:
0.47
Market Cap:
$221.82M
Revenue:
-
Net Income/Loss:
$-179.82M
P/E Ratio:
-0.4463
EPS:
-2.21
Net Cash Flow:
$-159.16M
1W Performance:
-1.36%
1M Performance:
+12.37%
6M Performance:
-16.41%
1Y Performance:
+18.44%
1-Day Range:
$0.9745
$0.9999
1-Week Range:
$0.939
$1.03
52-Week Range:
$0.4525
$1.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Name
Gossamer Bio Inc
Sector
Industry
Phone
(858) 922-0718
Address
3013 SCIENCE PARK, SAN DIEGO, CA
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Dec-07-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-07-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-07-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-20-22 | Initiated | Goldman | Buy |
| Sep-21-22 | Initiated | JP Morgan | Neutral |
| Sep-19-22 | Initiated | Wedbush | Outperform |
| Apr-18-22 | Initiated | Raymond James | Outperform |
| Apr-06-22 | Initiated | UBS | Buy |
| Jan-10-22 | Upgrade | SMBC Nikko | Neutral → Outperform |
| Nov-09-21 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-21-21 | Resumed | Piper Sandler | Overweight |
| Jun-29-20 | Initiated | H.C. Wainwright | Buy |
| Apr-22-20 | Initiated | Piper Sandler | Overweight |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-30-19 | Initiated | Berenberg | Buy |
| Mar-05-19 | Initiated | Barclays | Overweight |
| Mar-05-19 | Initiated | BofA/Merrill | Buy |
| Mar-05-19 | Initiated | Evercore ISI | Outperform |
| Mar-05-19 | Initiated | SVB Leerink | Outperform |
View All
Gossamer Bio Inc Stock (GOSS) Latest News
Financial Fitness Check: Examining Gossamer Bio Inc (GOSS)’s Key Ratios - The Dwinnex
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.8% in September - MarketBeat
Analysts review Gossamer Bio Inc’s rating - Knox Daily
GOSS (Gossamer Bio Inc) has impressive results - US Post News
A company insider recently sold 1,908 shares of Gossamer Bio Inc [GOSS]. Should You Sale? - Knox Daily
GoDaddy (NYSE:GDDY) PT Raised to $185.00 at Barclays - MarketBeat
It makes sense and dollars to buy Gevo Inc (GEVO) stock - SETE News
Gaining Ground: Gossamer Bio Inc (GOSS) Closes Lower at 0.99, Down -0.61 - The Dwinnex
NEA Management Company LLC Buys 2,255,025 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Keeping an Eye on Globus Medical Inc (GMED) After Insider Trading Activity - Knox Daily
NEA Management Company LLC Buys 2,255,025 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat
Analysts review Godaddy Inc’s rating - Knox Daily
A significant driver of top-line growth: Gossamer Bio Inc (GOSS) - SETE News
Is GlycoMimetics Inc (GLYC) a threat to investors? - US Post News
Globus Medical's (NYSE:GMED) investors will be pleased with their favorable 42% return over the last year - Yahoo Finance
Piper Sandler Downgrades GoDaddy (GDDY) - MSN
GOSS stock rated an Outperform by Oppenheimer - Knox Daily
Examining GOSS’s book value per share for the latest quarter - US Post News
GoDaddy downgraded by Piper Sandler with a new price target - Quantisnow
Gossamer Bio's Market Cap Up US$29m Following Year Of Insider Stock Buying - Simply Wall St
Choreo LLC Makes New Investment in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
GOSS Stock on the Rise: A Promising Investment - The InvestChronicle
Federated Hermes Inc. Has $2.76 Million Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Gossamer Bio shares maintain Buy rating on additional trial data By Investing.com - Investing.com Australia
Analytical Lens: Exploring GlycoMimetics Inc (GLYC)’s Financial Story Through Ratios - The Dwinnex
Gossamer Bio shares maintain Buy rating on additional trial data - Investing.com India
Gossamer Bio, Inc. (NASDAQ:GOSS) Sees Significant Drop in Short Interest - Defense World
Gossamer Bio shares maintain Buy rating on additional trial data By Investing.com - Investing.com Canada
For Gevo Inc [GEVO], Analyst sees a rise to $2. What next? - The DBT News
Gossamer Bio shares maintain Buy rating on additional trial data - Investing.com
Financial Snapshot: Analyzing Gevo Inc (GEVO)’s Key Ratio Metrics - The Dwinnex
Galmed Pharmaceuticals Soars Nearly 500% Amid Nasdaq Compliance and Short Squeeze - TipRanks
Gossamer Bio (NASDAQ:GOSS) Given Buy Rating at HC Wainwright - Defense World
Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.2% in August - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Given "Buy" Rating at HC Wainwright - MarketBeat
Take off with Gossamer Bio Inc (GOSS): Get ready for trading - SETE News
Recent Insider Activity Suggests Potential Gains for Gossamer Bio Inc (GOSS) - Knox Daily
Daily Market Movement: Gossamer Bio Inc (GOSS) Sees a 4.70 Increase, Closing at 0.92 - The Dwinnex
Gossamer Bio Inc (GOSS) shows promising results - US Post News
TD Asset Management Inc Purchases 219,238 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Gossamer Bio Inc [GOSS] stock for 1,260 USD was sold by Aranda Richard - Knox Daily
Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Bought by Acadian Asset Management LLC - MarketBeat
Taking on analysts’ expectations and winning: Gossamer Bio Inc (GOSS) - SETE News
Piper Sandler maintains Overweight rating on Gossamer Bio shares - Investing.com
Acadian Asset Management LLC Has $3.24 Million Holdings in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Piper Sandler maintains Overweight rating on Gossamer Bio shares - Investing.com India
GOSS’s Market Whiplash: -2.45% YTD Decline, 11.96% Rise in 30 Days - The InvestChronicle
Piper Sandler maintains Overweight rating on Gossamer Bio shares By Investing.com - Investing.com UK
Upward Trajectory: Gossamer Bio Inc (GOSS) Posts a Slidee, Closing at 0.89 - The Dwinnex
Monaco Asset Management SAM Has $2.46 Million Stake in Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat
Examining Gossamer Bio Inc (GOSS) stock is warranted - US Post News
Gossamer Bio Inc Stock (GOSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):